Caroline Leps, Paul Naseef, Elham Almoli, Daniel Kane, Nancy Nancy, Melissa Walker, John Kingdom, Sebastian R Hobson
Objectives: This study compares maternal and neonatal outcomes between preterm vacuum and forceps-assisted vaginal births and evaluates preterm outcomes between those <34 + 0 weeks gestation to those ≥34 + 0.
Methods: This study is a single-center retrospective cohort study of all singleton assisted vaginal births during 2014-2021. Delivery data and data on neonatal and pregnant patient outcomes were extracted from electronic medical records. Categorical variables were described by frequencies and percentages, and adjusted odds ratios (aORs) were calculated using logistic regression.
Results: There were 5095 assisted vaginal births during this period, of which 246 were preterm (171 vacuum and 75 forceps assisted). Neonatal head ultrasounds were less common after preterm vacuum- than after preterm forceps-assisted births (6.4 vs. 13.3%). Of those under 34 weeks (18 vacuum and 18 forceps assisted), there were identical rates of head ultrasound in each group (n = 7, 38.9%). Rates of Grade 1 intraventricular hemorrhage were the same between the vacuum- and forceps-assisted groups under 34 weeks (n = 5, 27.7%). No major intra- or extra-cranial bleeds were found among infants who underwent a vacuum- or forceps-assisted birth before 34 weeks. Maternal outcomes showed significantly lower odds of obstetric anal sphincter injury (aOR 0.26) and episiotomy (aOR 0.16) with preterm vacuum compared to preterm forceps-assisted births.
Conclusion: This study adds to a small but growing body of literature that supports maternal and neonatal safety of vacuum-assisted birth under 34 weeks' gestation, in comparison with the use of forceps, when assisted vaginal birth is required. Larger prospective registry-based studies are suggested to determine the robustness of this conclusion.
{"title":"Preterm assisted vaginal births and associated maternal and neonatal outcomes: A retrospective study in a tertiary hospital.","authors":"Caroline Leps, Paul Naseef, Elham Almoli, Daniel Kane, Nancy Nancy, Melissa Walker, John Kingdom, Sebastian R Hobson","doi":"10.1002/ijgo.70802","DOIUrl":"https://doi.org/10.1002/ijgo.70802","url":null,"abstract":"<p><strong>Objectives: </strong>This study compares maternal and neonatal outcomes between preterm vacuum and forceps-assisted vaginal births and evaluates preterm outcomes between those <34 + 0 weeks gestation to those ≥34 + 0.</p><p><strong>Methods: </strong>This study is a single-center retrospective cohort study of all singleton assisted vaginal births during 2014-2021. Delivery data and data on neonatal and pregnant patient outcomes were extracted from electronic medical records. Categorical variables were described by frequencies and percentages, and adjusted odds ratios (aORs) were calculated using logistic regression.</p><p><strong>Results: </strong>There were 5095 assisted vaginal births during this period, of which 246 were preterm (171 vacuum and 75 forceps assisted). Neonatal head ultrasounds were less common after preterm vacuum- than after preterm forceps-assisted births (6.4 vs. 13.3%). Of those under 34 weeks (18 vacuum and 18 forceps assisted), there were identical rates of head ultrasound in each group (n = 7, 38.9%). Rates of Grade 1 intraventricular hemorrhage were the same between the vacuum- and forceps-assisted groups under 34 weeks (n = 5, 27.7%). No major intra- or extra-cranial bleeds were found among infants who underwent a vacuum- or forceps-assisted birth before 34 weeks. Maternal outcomes showed significantly lower odds of obstetric anal sphincter injury (aOR 0.26) and episiotomy (aOR 0.16) with preterm vacuum compared to preterm forceps-assisted births.</p><p><strong>Conclusion: </strong>This study adds to a small but growing body of literature that supports maternal and neonatal safety of vacuum-assisted birth under 34 weeks' gestation, in comparison with the use of forceps, when assisted vaginal birth is required. Larger prospective registry-based studies are suggested to determine the robustness of this conclusion.</p>","PeriodicalId":14164,"journal":{"name":"International Journal of Gynecology & Obstetrics","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146003683","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Primary extrauterine peritoneal choriocarcinoma mistaken for ectopic pregnancy: A case report with ultrasound, MRI, surgical images.","authors":"Céline Saaifan, Marie Devred, Olivier Vabret","doi":"10.1002/ijgo.70829","DOIUrl":"https://doi.org/10.1002/ijgo.70829","url":null,"abstract":"","PeriodicalId":14164,"journal":{"name":"International Journal of Gynecology & Obstetrics","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146003669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yasemin Erkal Aksoy, Habibe Bay Özçalık, Bihter Akın
Objectives: This study assessed Turkish women's attitudes toward intimate partner violence (IPV) and their levels of social support and depression.
Methods: This descriptive cross-sectional study collected data online between April 2022 and December 2023. The sample consisted of 405 women. The data were collected using a personal information form, the Intimate Partner Violence Attitude Scale-Revised (IPVAS-R), the Multidimensional Scale of Perceived Social Support (MSPSS), and the Beck Depression Inventory (BDI).
Results: The participants' mean total IPVAS-R, MSPSS, and BDI scores were 35.41 ± 8.86 (18-59), 68.44 ± 14.34 (20-84), and 11.56 ± 9.63 (0-63), respectively. Approximately 22% of participants reported being exposed to emotional violence, 20% to economic violence, and 9.6% to physical violence. Participants' total IPVAS-R and MSPSS scores were negatively correlated (P < 0.01). Participants' total IPVAS-R and BDI scores were positively correlated (P < 0.01).
Conclusion: This study found that women's attitudes toward IPV acceptance correlated negatively with their levels of social support and positively with their levels of depression.
{"title":"Determining Turkish women's attitudes toward intimate partner violence and their levels of social support and depression: A cross-sectional study.","authors":"Yasemin Erkal Aksoy, Habibe Bay Özçalık, Bihter Akın","doi":"10.1002/ijgo.70815","DOIUrl":"https://doi.org/10.1002/ijgo.70815","url":null,"abstract":"<p><strong>Objectives: </strong>This study assessed Turkish women's attitudes toward intimate partner violence (IPV) and their levels of social support and depression.</p><p><strong>Methods: </strong>This descriptive cross-sectional study collected data online between April 2022 and December 2023. The sample consisted of 405 women. The data were collected using a personal information form, the Intimate Partner Violence Attitude Scale-Revised (IPVAS-R), the Multidimensional Scale of Perceived Social Support (MSPSS), and the Beck Depression Inventory (BDI).</p><p><strong>Results: </strong>The participants' mean total IPVAS-R, MSPSS, and BDI scores were 35.41 ± 8.86 (18-59), 68.44 ± 14.34 (20-84), and 11.56 ± 9.63 (0-63), respectively. Approximately 22% of participants reported being exposed to emotional violence, 20% to economic violence, and 9.6% to physical violence. Participants' total IPVAS-R and MSPSS scores were negatively correlated (P < 0.01). Participants' total IPVAS-R and BDI scores were positively correlated (P < 0.01).</p><p><strong>Conclusion: </strong>This study found that women's attitudes toward IPV acceptance correlated negatively with their levels of social support and positively with their levels of depression.</p>","PeriodicalId":14164,"journal":{"name":"International Journal of Gynecology & Obstetrics","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146003705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: To investigate whether intraoperative confirmation of the disappearance of uterine cavity blood flow using color Doppler during manual vacuum aspiration (MVA) for missed miscarriage reduces the occurrence of retained products of conception (RPOC).
Methods: We conducted a retrospective cohort study of 202 patients who underwent MVA for missed miscarriage before 12 weeks of gestation at the University of Yamanashi between April 2019 and July 2025. Patients were divided into a flow-confirmation group, in which intraoperative transvaginal ultrasound with color Doppler was used to confirm the disappearance of blood flow, and a non-confirmation group. The primary outcome was the occurrence of RPOC diagnosed by postoperative ultrasound. Patient characteristics and surgical variables were compared between groups.
Results: RPOC occurred in 25 of 202 cases (12%). None of the 25 patients in the flow-confirmation group developed RPOC, whereas 14% of the 177 patients in the non-confirmation group did (P = 0.04). The surgeon's years of experience (2.6 ± 1.6 vs 4.9 ± 4.7 years, P = 0.004) and postoperative follow-up duration (1.9 ± 1.0 vs 3.3 ± 4.3 weeks, P = 0.02) were significantly shorter in the flow-confirmation group, but no other significant differences were found in baseline characteristics or surgical variables.
Conclusion: Intraoperative confirmation of the disappearance of uterine cavity blood flow using color Doppler during MVA is a simple, safe, and effective technique to prevent RPOC. This approach may reduce the need for repeat surgery and postoperative hemorrhage and could be incorporated into standard MVA protocols.
{"title":"Intraoperative color Doppler during manual vacuum aspiration prevents retained products of conception.","authors":"Tatsuya Yoshihara, Keito Nakayama, Dai Miyashita, Satoko Sasatsu, Maki Ogi, Yosuke Ono, Osamu Yoshino","doi":"10.1002/ijgo.70810","DOIUrl":"https://doi.org/10.1002/ijgo.70810","url":null,"abstract":"<p><strong>Objective: </strong>To investigate whether intraoperative confirmation of the disappearance of uterine cavity blood flow using color Doppler during manual vacuum aspiration (MVA) for missed miscarriage reduces the occurrence of retained products of conception (RPOC).</p><p><strong>Methods: </strong>We conducted a retrospective cohort study of 202 patients who underwent MVA for missed miscarriage before 12 weeks of gestation at the University of Yamanashi between April 2019 and July 2025. Patients were divided into a flow-confirmation group, in which intraoperative transvaginal ultrasound with color Doppler was used to confirm the disappearance of blood flow, and a non-confirmation group. The primary outcome was the occurrence of RPOC diagnosed by postoperative ultrasound. Patient characteristics and surgical variables were compared between groups.</p><p><strong>Results: </strong>RPOC occurred in 25 of 202 cases (12%). None of the 25 patients in the flow-confirmation group developed RPOC, whereas 14% of the 177 patients in the non-confirmation group did (P = 0.04). The surgeon's years of experience (2.6 ± 1.6 vs 4.9 ± 4.7 years, P = 0.004) and postoperative follow-up duration (1.9 ± 1.0 vs 3.3 ± 4.3 weeks, P = 0.02) were significantly shorter in the flow-confirmation group, but no other significant differences were found in baseline characteristics or surgical variables.</p><p><strong>Conclusion: </strong>Intraoperative confirmation of the disappearance of uterine cavity blood flow using color Doppler during MVA is a simple, safe, and effective technique to prevent RPOC. This approach may reduce the need for repeat surgery and postoperative hemorrhage and could be incorporated into standard MVA protocols.</p>","PeriodicalId":14164,"journal":{"name":"International Journal of Gynecology & Obstetrics","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145998196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Omri Segal, Shir Koren, Raanan Meyer, Michal Axelrod, Keren Zloto, David Stockheim, Roy Mashiach, Shlomi Toussia-Cohen
Objective: Uterine perforation (UP) is a rare complication, most commonly occurring during dilatation and evacuation, intrauterine device (IUD) insertion, or hysteroscopy. While a history of UP may increase the risk of complications in future pregnancies, data on this association remains limited. The aim of the present study was to evaluate obstetric and neonatal outcomes in subsequent pregnancies following documented UP.
Methods: A retrospective cohort study of all patients with prior UP delivered between June 2011 to May 2022 was conducted at a single tertiary medical center. The patients were compared to a control group without a history of UP using propensity score matching (1:8 ratio). Primary outcomes were: (1) maternal composite adverse outcome including uterine rupture, placental abruption, postpartum hemorrhage (PPH), blood products transfusion, and hysterectomy and (2) neonatal composite adverse outcome including low Apgar score, low cord pH, need for mechanical ventilation, and neonatal intensive care unit (NICU) hospitalization. Secondary outcomes included specific maternal and neonatal adverse events.
Results: The study group included 28 patients compared to 224 patients. There were no significant differences between the two groups in the composite maternal and neonatal outcomes. Two secondary outcomes-PPH and placenta accreta spectrum (PAS)-were significantly more common in the study group. One patient from the study group had a uterine rupture, and one patient underwent cesarean hysterectomy following a placenta percreta. These outcomes did not reach statistical significance.
Conclusion: A history of UP was not associated with composite maternal and neonatal complications. Higher rates of PPH and PAS were recorded in patients with prior UP.
{"title":"Uterine cavity perforation-obstetric and neonatal outcomes of subsequent pregnancies.","authors":"Omri Segal, Shir Koren, Raanan Meyer, Michal Axelrod, Keren Zloto, David Stockheim, Roy Mashiach, Shlomi Toussia-Cohen","doi":"10.1002/ijgo.70830","DOIUrl":"https://doi.org/10.1002/ijgo.70830","url":null,"abstract":"<p><strong>Objective: </strong>Uterine perforation (UP) is a rare complication, most commonly occurring during dilatation and evacuation, intrauterine device (IUD) insertion, or hysteroscopy. While a history of UP may increase the risk of complications in future pregnancies, data on this association remains limited. The aim of the present study was to evaluate obstetric and neonatal outcomes in subsequent pregnancies following documented UP.</p><p><strong>Methods: </strong>A retrospective cohort study of all patients with prior UP delivered between June 2011 to May 2022 was conducted at a single tertiary medical center. The patients were compared to a control group without a history of UP using propensity score matching (1:8 ratio). Primary outcomes were: (1) maternal composite adverse outcome including uterine rupture, placental abruption, postpartum hemorrhage (PPH), blood products transfusion, and hysterectomy and (2) neonatal composite adverse outcome including low Apgar score, low cord pH, need for mechanical ventilation, and neonatal intensive care unit (NICU) hospitalization. Secondary outcomes included specific maternal and neonatal adverse events.</p><p><strong>Results: </strong>The study group included 28 patients compared to 224 patients. There were no significant differences between the two groups in the composite maternal and neonatal outcomes. Two secondary outcomes-PPH and placenta accreta spectrum (PAS)-were significantly more common in the study group. One patient from the study group had a uterine rupture, and one patient underwent cesarean hysterectomy following a placenta percreta. These outcomes did not reach statistical significance.</p><p><strong>Conclusion: </strong>A history of UP was not associated with composite maternal and neonatal complications. Higher rates of PPH and PAS were recorded in patients with prior UP.</p>","PeriodicalId":14164,"journal":{"name":"International Journal of Gynecology & Obstetrics","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146003694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Xiaoli Zhao, Wei Zhang, Meiyan Mi, Haixing Wang, Yiqian Wang, Li Feng, Hongbin Wang
Objective: Adenomyosis is a debilitating gynecologic condition. The present study aimed to compare the effects of laparoscopic total hysterectomy (LTH) and high-intensity focused ultrasound (HIFU) on pain relief, menstrual blood loss, and sexual function over a 12-month follow-up period in patients with adenomyosis.
Methods: A retrospective cohort study was conducted at our institution, including patients with adenomyosis who underwent LTH or HIFU. Propensity score matching (PSM) was performed to control for baseline differences in age, pictorial blood loss assessment chart (PBAC) score, numerical rating scale (NRS) for pain, and female sexual function index (FSFI) score, with a caliper value of 0.05.
Results: A total of 149 patients were included after PSM (LTH: n = 74, HIFU: n = 75). Both groups demonstrated significant reductions in pain scores over time, but the LTH group exhibited more rapid and sustained pain relief, with NRS scores at 6 months (LTH: 1.92 ± 1.06, HIFU: 3.58 ± 1.32, P < 0.001) and 12 months (LTH: 1.78 ± 1.03, HIFU: 2.94 ± 1.27, P < 0.001).
Conclusion: LTH and HIFU relieve adenomyosis differently, highlighting the need for personalized treatment based on symptom relief, function, and fertility.
{"title":"Comparative study of female sexual function in adenomyosis patients who received the treatment of intensity-focused ultrasound ablation or laparoscopic total hysterectomy.","authors":"Xiaoli Zhao, Wei Zhang, Meiyan Mi, Haixing Wang, Yiqian Wang, Li Feng, Hongbin Wang","doi":"10.1002/ijgo.70824","DOIUrl":"https://doi.org/10.1002/ijgo.70824","url":null,"abstract":"<p><strong>Objective: </strong>Adenomyosis is a debilitating gynecologic condition. The present study aimed to compare the effects of laparoscopic total hysterectomy (LTH) and high-intensity focused ultrasound (HIFU) on pain relief, menstrual blood loss, and sexual function over a 12-month follow-up period in patients with adenomyosis.</p><p><strong>Methods: </strong>A retrospective cohort study was conducted at our institution, including patients with adenomyosis who underwent LTH or HIFU. Propensity score matching (PSM) was performed to control for baseline differences in age, pictorial blood loss assessment chart (PBAC) score, numerical rating scale (NRS) for pain, and female sexual function index (FSFI) score, with a caliper value of 0.05.</p><p><strong>Results: </strong>A total of 149 patients were included after PSM (LTH: n = 74, HIFU: n = 75). Both groups demonstrated significant reductions in pain scores over time, but the LTH group exhibited more rapid and sustained pain relief, with NRS scores at 6 months (LTH: 1.92 ± 1.06, HIFU: 3.58 ± 1.32, P < 0.001) and 12 months (LTH: 1.78 ± 1.03, HIFU: 2.94 ± 1.27, P < 0.001).</p><p><strong>Conclusion: </strong>LTH and HIFU relieve adenomyosis differently, highlighting the need for personalized treatment based on symptom relief, function, and fertility.</p>","PeriodicalId":14164,"journal":{"name":"International Journal of Gynecology & Obstetrics","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145998248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Preterm birth occurs in approximately 10% of all pregnancies, and is not only the leading cause of neonatal mortality but also a major contributor to short- and long-term morbidities due to immaturity. Preterm birth has also been linked to an increased risk of maternal cardiovascular and cerebrovascular diseases, making it a critical concern in both perinatal medicine and women's lifelong health. Effective treatment requires interventions during threatened preterm labor, and several tocolytic agents have been developed and used in clinical practice. However, no pharmacological agent has been shown to prolong gestation and improve neonatal outcomes. Nifedipine, a calcium channel blocker, is widely used as a first-line tocolytic agent because of its oral administration route and relatively favorable safety profile compared with other drugs. Evidence from randomized controlled trials, meta-analyses, and Cochrane reviews suggests that nifedipine can delay delivery for a short period; however, robust evidence demonstrating sustained prolongation of pregnancy or improved neonatal survival is still lacking. Moreover, data on maternal hemodynamic changes and fetal effects are limited, highlighting the need for optimal dosing strategies and monitoring protocols. In this study, we discuss the clinical significance and limitations of nifedipine in the management of threatened preterm labor and outlined future directions. Future studies should involve large and homogeneous populations, continuous assessment of maternal hemodynamics, and application of novel biomarkers to support individualized therapy. Accumulation of such evidence is expected to optimize the management of threatened preterm labor and ultimately improve outcomes for mothers and infants.
{"title":"Therapeutic role of nifedipine in threatened preterm labor: Current evidence and future perspectives.","authors":"Hikaru Imatake, Yoshitsugu Chigusa, Haruta Mogami, Satoshi Morita, Masaki Mandai","doi":"10.1002/ijgo.70816","DOIUrl":"https://doi.org/10.1002/ijgo.70816","url":null,"abstract":"<p><p>Preterm birth occurs in approximately 10% of all pregnancies, and is not only the leading cause of neonatal mortality but also a major contributor to short- and long-term morbidities due to immaturity. Preterm birth has also been linked to an increased risk of maternal cardiovascular and cerebrovascular diseases, making it a critical concern in both perinatal medicine and women's lifelong health. Effective treatment requires interventions during threatened preterm labor, and several tocolytic agents have been developed and used in clinical practice. However, no pharmacological agent has been shown to prolong gestation and improve neonatal outcomes. Nifedipine, a calcium channel blocker, is widely used as a first-line tocolytic agent because of its oral administration route and relatively favorable safety profile compared with other drugs. Evidence from randomized controlled trials, meta-analyses, and Cochrane reviews suggests that nifedipine can delay delivery for a short period; however, robust evidence demonstrating sustained prolongation of pregnancy or improved neonatal survival is still lacking. Moreover, data on maternal hemodynamic changes and fetal effects are limited, highlighting the need for optimal dosing strategies and monitoring protocols. In this study, we discuss the clinical significance and limitations of nifedipine in the management of threatened preterm labor and outlined future directions. Future studies should involve large and homogeneous populations, continuous assessment of maternal hemodynamics, and application of novel biomarkers to support individualized therapy. Accumulation of such evidence is expected to optimize the management of threatened preterm labor and ultimately improve outcomes for mothers and infants.</p>","PeriodicalId":14164,"journal":{"name":"International Journal of Gynecology & Obstetrics","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145998202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"EXPRESSION OF CONCERN: A Randomized Controlled Trial of Clomifene Citrate, Metformin, And Pioglitazone Versus Letrozole, Metformin, And Pioglitazone For Clomifene-Citrate-Resistant Polycystic Ovary Syndrome.","authors":"","doi":"10.1002/ijgo.70739","DOIUrl":"https://doi.org/10.1002/ijgo.70739","url":null,"abstract":"","PeriodicalId":14164,"journal":{"name":"International Journal of Gynecology & Obstetrics","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145998253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Uterine leiomyomas are benign gynecologic tumors that occur in approximately 80% of women of reproductive age. Although often asymptomatic, these tumors may, in some cases, require gynecologic intervention. Conventional imaging tools, such as ultrasonography (US) and magnetic resonance imaging (MRI), are most commonly used to guide treatment selection. However, none of these methods provides definitive criteria for qualifying patients for medical, non-invasive, or surgical therapy. Therefore, there is a pressing need to develop innovative tools that improve the evaluation of uterine masses and allow for safer and more effective patient stratification for appropriate treatment options. In this context, the relatively recent development of techniques for assessing tissue stiffness offers promising possibilities. The aim of this review was to analyze available research on the use of ultrasound elastography and magnetic resonance elastography in the evaluation of uterine leiomyomas. It highlights the feasibility of these techniques in assessing the viscoelastic properties of leiomyomas and explores their potential application in differential diagnosis and treatment planning.
{"title":"Evaluation of tissue stiffness: A deeper insight into the nature of uterine leiomyomas and its possible clinical applications.","authors":"Bogdan Obrzut, Vitaliy Atamaniuk, Danuta Vasilevska, Łukasz Hańczyk, Marzanna Obrzut","doi":"10.1002/ijgo.70809","DOIUrl":"https://doi.org/10.1002/ijgo.70809","url":null,"abstract":"<p><p>Uterine leiomyomas are benign gynecologic tumors that occur in approximately 80% of women of reproductive age. Although often asymptomatic, these tumors may, in some cases, require gynecologic intervention. Conventional imaging tools, such as ultrasonography (US) and magnetic resonance imaging (MRI), are most commonly used to guide treatment selection. However, none of these methods provides definitive criteria for qualifying patients for medical, non-invasive, or surgical therapy. Therefore, there is a pressing need to develop innovative tools that improve the evaluation of uterine masses and allow for safer and more effective patient stratification for appropriate treatment options. In this context, the relatively recent development of techniques for assessing tissue stiffness offers promising possibilities. The aim of this review was to analyze available research on the use of ultrasound elastography and magnetic resonance elastography in the evaluation of uterine leiomyomas. It highlights the feasibility of these techniques in assessing the viscoelastic properties of leiomyomas and explores their potential application in differential diagnosis and treatment planning.</p>","PeriodicalId":14164,"journal":{"name":"International Journal of Gynecology & Obstetrics","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145989154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Response: \"First do no harm: Fundal pressure during labor-How safe is it?\"","authors":"Or Eliner, G Shechter Maor","doi":"10.1002/ijgo.70814","DOIUrl":"https://doi.org/10.1002/ijgo.70814","url":null,"abstract":"","PeriodicalId":14164,"journal":{"name":"International Journal of Gynecology & Obstetrics","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145989144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}